亚甲基四氢叶酸还原酶缺乏症致脑积水患儿2例临床及MTHFR基因变异分析

doi:10.12372/jcp.2023.22e1574

摘要/Abstract

摘要：

目的探讨以婴儿期脑积水为突出表现的亚甲基四氢叶酸还原酶缺乏症患儿的临床特点、治疗及预后。方法 2例患儿因脑积水于北京大学第一医院儿科就诊，经血清总同型半胱氨酸、血液氨基酸及酰基肉碱谱、尿有机酸和基因分析确诊，对患儿的临床特点、代谢异常、MTHFR基因变异、诊断、治疗及预后等进行回顾性研究。结果 2例患儿为男童，分别于2月龄及4月龄起病，以脑积水及癫痫发作为主要表现，血清总同型半胱氨酸显著增高，血甲硫氨酸降低或处于正常低值，尿有机酸正常，头颅影像检查发现严重脑积水。两患儿服用甜菜碱、亚叶酸钙、钴胺素等治疗后血清总同型半胱氨酸下降，侧脑室腹腔分流手术后颅压改善，但智力运动发育明显迟缓，仍有癫痫发作。两患儿MTHFR基因均存在复合杂合变异，确诊为亚甲基四氢叶酸还原酶缺乏症所致同型半胱氨酸血症2型。4种变异中1种为已知致病变异，3种为未报道的新变异。结论亚甲基四氢叶酸还原酶缺乏症患儿可于婴儿早期发生脑积水及癫痫等严重神经系统疾病，血清总同型半胱氨酸及基因检测是早期诊断的关键。

关键词: 脑积水, 亚甲基四氢叶酸还原酶, 同型半胱氨酸血症, MTHFR基因

Abstract:

Objective To investigate the clinical characteristics, treatment, and prognosis of hydrocephalus due to methylenetetrahydrofolate reductase (MTHFR) deficiency caused by MTHFR gene variations. Methods Two boys admitted to the Department of Pediatrics of Peking University First Hospital with hydrocephalus were diagnosed by serum total homocysteine, blood amino acid and acylcarnitine profile, urinary organic acid, and genetic analysis. The clinical manifestations, biochemical features, MTHFR gene variants, diagnosis, therapy, and prognosis were retrospectively analyzed. Results Two children presented with hydrocephalus and seizures at 2 and 4 months of age, respectively, with significantly increased serum total homocysteine, reduced or low normal blood methionine, normal urinary organic acids, and severe hydrocephalus on cranial imaging. Serum total homocysteine decreased after treatment with betaine, calcium folinic acid, and cobalamin in both children, and intracranial pressure improved after lateral ventriculoperitoneal shunt surgery, but intellectual and motor development was delayed and seizures were still present. The diagnosis of homocysteinemia type 2 due to MTHFR deficiency was confirmed by the presence of compound heterozygous variants in the MTHFR gene in both children. One of the 4 variants was a known pathogenic variant and 3 were unreported novel variants. Conclusion Children with MTHFR deficiency may develop severe neurological symptoms such as hydrocephalus and epilepsy in early infancy, and serum total homocysteine and gene analysis are keys for the diagnosis.

Key words: hydrocephalus, methylenetetrahydrofolate reductase, homocysteinemia, MTHFR gene

董慧, 陈哲晖, 马雪, 张尧, 宋金青, 金颖, 李梦秋, 张宏武, 姚红新, 杨艳玲. 亚甲基四氢叶酸还原酶缺乏症致脑积水患儿2例临床及MTHFR基因变异分析[J]. 临床儿科杂志, 2023, 41(2): 108-112.

DONG Hui, CHEN Zhehui, MA Xue, ZHANG Yao, SONG Jinqing, JIN Ying, LI Mengqiu, ZHANG Hongwu, YAO Hongxin, YANG Yanling. Two cases of hydrocephalus due to methylenetetrahydrofolate reductase deficiency and MTHFR gene variants[J]. Journal of Clinical Pediatrics, 2023, 41(2): 108-112.

图/表 2

参考文献 23

[1]	Aljassim N, Alfadhel M, Nashabat M, et al. Clinical presentation of seven patients with methy-lenetetrahydrofolate reductase deficiency[J]. Mol Genet Metab Rep, 2020, 25: 100644.
[2]	Tortorelli S, Turgeon CT, Lim JS, et al. Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry[J]. J Pediatr, 2010, 157(2):271-275. doi: 10.1016/j.jpeds.2010.02.027
[3]	李东晓, 张尧, 张宏武, 等. 高同型半胱氨酸血症的诊断、治疗与预防专家共识[J]. 罕少疾病杂志, 2022, 29(6): 1-4.
[4]	顾学范, 韩连书, 余永国. 中国新生儿遗传代谢病筛查现状及展望[J]. 罕见病研究, 2022, 1(1): 13-19.
[5]	Li DX, Li XY, Dong H, et al. Eight novel mutations of CBS gene in nine Chinese patients with classical homocystinuria[J]. World J Pediatr, 2018, 14(2): 197-203. doi: 10.1007/s12519-018-0135-9 pmid: 29508359
[6]	中国妇幼保健协会出生缺陷防治与分子遗传分会. 甲基丙二酸血症合并同型半胱氨酸血症cblC型所致脑积水诊疗与预防专家共识[J]. 中华新生儿科杂志, 2022, 37 (6): 481-487
[7]	Garcia-Bonilla M, McAllister JP, Limbrick DD. Genetics and Molecular Pathogenesis of Human Hydrocephalus[J]. Neurol India, 2021, 69(Supplement): S268-S274.
[8]	Bauer DF, Baird LC, Klimo P, et al. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Treatment of Pediatric Hydrocephalus: update of the 2014 guidelines[J]. Neurosurgery, 2020, 87(6): 1071-1075. doi: 10.1093/neuros/nyaa434 pmid: 34791462
[9]	谢艺, 袁义, 陈瑜, 等. 早发型亚甲基四氢叶酸还原酶缺陷症1例临床及基因分析[J]. 临床儿科杂志, 2018, 36(9): 658-661.
[10]	Richard E, Desviat LR, Ugarte M, et al. Oxidative stress and apoptosis in homocystinuria patients with genetic remethylation defects[J]. J Cell Biochem, 2013, 114(1): 183-191. doi: 10.1002/jcb.24316 pmid: 22887477
[11]	Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17: 405-424. doi: 10.1038/gim.2015.30 pmid: 25741868
[12]	王峤, 刘靖, 刘玉鹏, 等. 亚甲基四氢叶酸还原酶缺陷导致学童精神分裂症[J]. 中国当代儿科杂志, 2014, 16(1): 62-66.
[13]	Al Mutairi F. Hyperhomocysteinemia: clinical insights[J]. J Cent Nerv Syst Dis, 2020, 12: 1179573520962230.
[14]	Mudd SH, Uhlendorf BW, Freeman JM, et al. Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity[J]. Biochem Biophys Res Commun, 1972, 46(2): 905-912. doi: 10.1016/S0006-291X(72)80227-4
[15]	Huemer M, Mulder-Bleile R, Burda P, et al. Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency[J]. J Inherit Metab Dis, 2016, 39(1): 115-124. doi: 10.1007/s10545-015-9860-6 pmid: 26025547
[16]	Huemer M, Diodato D, Schwahn B, et al. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency[J]. J Inherit Metab Dis, 2017. 40(1): 21-48. doi: 10.1007/s10545-016-9991-4 pmid: 27905001
[17]	北京医学会罕见病分会, 中国妇幼保健协会儿童疾病和保健分会遗传代谢学组, 中国医师协会青春期医学专业委员会临床遗传学组及生化学组, 等. 遗传代谢病所致贫血的诊疗专家共识[J]. 标记免疫分析与临床, 2021, 28(10): 1626-1634.
[18]	Goyette P, Rosenblatt D, Rozen R. Homocystinuria (methylenetetra hydrofolate reductase deficiency) and mutation of factor gene[J]. Inherit Metab Dis, 1998, 21(6): 690-691. doi: 10.1023/A:1005457206323
[19]	Froese DS, Huemer M, Suormala T, et al. Mutation update and review of severe methylenetetrahydrofolate reductase Deficiency[J]. Hum Mutat, 2016, 37(5): 427-438. doi: 10.1002/humu.22970 pmid: 26872964
[20]	Burda P, Schafer A, Suormala T, et al. Insights into severe 5, 10-methylenetetrahydrofolate reductase deficiency: molecular genetic and enzymatic characterization of 76 patients[J]. Hum Mutat, 2015, 36(6): 611-621. doi: 10.1002/humu.22779
[21]	Tonetti C, Saudubray JM, Echenne B, et al. Relations between molecular and biological abnormalities in 11 families from siblings affected with methylenetetrahydrofolate reductase deficiency[J]. Eur J Pediatr, 2003, 162(7-8):466-475. doi: 10.1007/s00431-003-1196-9 pmid: 12733064
[22]	Tsang BL, Devine OJ, Cordero AM, et al. Assessing the association between the methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism and blood folate concentrations: a systematic review and meta-analysis of trials and observational studies[J]. Am J Clin Nutr, 2015, 101(6): 1286-1294. doi: 10.3945/ajcn.114.099994
[23]	Diekman EF, de Koning TJ, Verhoeven-Duif NM, et al. Survival and psychomotor development with early betaine treatment in patients with severe methylenetetrahydrofolate reductase deficiency[J]. JAMA Neurol, 2014, 71(2):188-194. doi: 10.1001/jamaneurol.2013.4915 pmid: 24323041